Divergent Influences of the Structurally Dissimilar Calcium Entry Blockers, Diltiazem and Verapamil, on Thyrotropin- and Gonadotropin-Releasing Hormone- Stimulated Anterior Pituitary Hormone Secretion in Man*
- 1 January 1985
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 60 (1) , 144-149
- https://doi.org/10.1210/jcem-60-1-144
Abstract
We have tested the influence of a new calcium ion channel antagonist, diltiazem, on hypothalamic releasing hormone-stimulated secretion of LH and other anterior pituitary hormones in man. To this end, six normal men received a continuous infusion of GnRH (1 μg/min) and TRH (2 μg/min) for 3 h under three different experimental conditions: 1) saline (control) infusion; 2) iv diltiazem (0.3 mg/kg bolus dose, and 0.002 mg/kg-min) infusion for 4 h beginning 1 h before releasing hormone injection; and 3) oral diltiazem (60 mg, every 6 h) administration for 1 week before pituitary stimulation. Blood was sampled at 10-min intervals for the subsequent immunoassay of LH, FSH, TSH, PRL, and GH concentrations and at hourly intervals for the assay of plasma diltiazem concentrations by high performance liquid chromatography. Despite sustained plasma diltiazem concentrations of 80–120 ng/ml during either iv or oral drug administration, the GnRH/TRH-stimulated release of LH, FSH, TSH, and PRL or the basal secretion of GH did not differ significantly from that during saline infusion. In contrast, when these subjects underwent the same infusion schedule using a structurally dissimilar calcium influx blocker, verapamil (5-mg bolus dose and 15 mg/h, continuous infusion), there was significant suppression of the delayed component of GnRH/TRH-stimulated LH release, with simultaneous enhancement of PRL secretion. We conclude that exogenously stimulated anterior pituitary hormone secretion in man exhibits differential susceptibility to the structurally discrete calcium entry blockers diltiazem and verapamil. Moreover, the differential influence of these two calcium ion channel antagonists on gonadotropes is distinct from that described in cardiac and smooth muscle cells.Keywords
This publication has 17 references indexed in Scilit:
- The Effect of Acute Hypercalcemia on Prolactin Release in ManHormone and Metabolic Research, 1981
- Direct measurement of the effect of potassium, calcium, veratridine, and and amphetamine on the rate of release of dopamine from superfused brain tissueLife Sciences, 1981
- Calcium Antagonists and Hormone Release. II. Effects of Verapamil on Basal, Gonadotropin-Releasing Hormoneand Thyrotropin-Releasing Hormone-Induced Pituitary Hormone Release in Normal SubjectsJournal of Clinical Endocrinology & Metabolism, 1980
- Rapid Regression of Pituitary Prolactinomas during Bromocriptine Treatment*Journal of Clinical Endocrinology & Metabolism, 1980
- Extracellular Ca++-Independent and -Dependent Components of the Biphasic Release of LH in Response to Luteinizing Hormone-Releasing Hormone in Vitro*Endocrinology, 1980
- Dopaminergic Mechanisms and Luteinizing Hormone Secretion. I. Acute Administration of the Dopamine Agonist Bromocriptine Does Not Inhibit Luteinizing Hormone Release in Hyperprolactinemic Women*Journal of Clinical Endocrinology & Metabolism, 1980
- Alteration of the Intracellular Calcium Level Stimulates Gonadotropin Release from Cultured Rat Anterior Pituitary Cells*Endocrinology, 1979
- Changes in Plasma Luteinizing Hormone-Releasing Hormone and Gonadotropin Concentrations during Constant Rate Intravenous Infusion of Luteinizing Hormone-Releasing Hormone in Cyclic Rats*Endocrinology, 1978
- Interactions of lead and calcium on the synaptosomal uptake of dopamine and cholineLife Sciences, 1977
- Some Effects of Energy-Transfer Inhibitors and of Ca++-Free or K+-Enhanced Media on the Release of Luteinizing Hormone (LH) from the Rat Pituitary Glandin Vitro1Endocrinology, 1968